Colossal Partners with US Government to Establish Endangered Species BioVault
Colossal Biosciences, the biotech company perhaps best known for its ambitious de-extinction projects, has announced a partnership with the U.S. Department of the Interior to establish what they're calling a "BioVault"—a repository designed to preserve genetic material from endangered species.
The initiative aims to safeguard DNA samples from species at risk of extinction, potentially providing future conservationists with tools to support recovery efforts. The BioVault would serve as a genetic archive, storing tissue samples, embryos, and other biological materials that could one day aid in breeding programs or restoration efforts.
The partnership arrives at a contentious moment for wildlife protection in the United States. The Trump administration has signaled intentions to weaken the Endangered Species Act, which has been the cornerstone of American conservation efforts for decades. Critics of the administration argue that rollbacks to the Act could accelerate habitat loss and reduce protections for vulnerable wildlife populations.
Conservation advocates have pointed to the BioVault as a complementary measure—preserving genetic diversity as a safety net even as regulatory protections face uncertainty. However, experts note that genetic preservation alone cannot substitute for habitat protection and habitat loss remains one of the primary drivers of species decline.
The project reflects growing interest in applying advanced biotechnology to conservation challenges. Colossal has previously worked on efforts to bring back the woolly mammoth and has developed expertise in gene editing and reproductive technologies that could theoretically be applied to endangered species recovery programs.